Compare Amphastar Pharmaceuticals Inc (AMPH) vs iShares Russell 2000 ETF (IWM) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

IWM (iShares Russell 2000 ETF) trades at $295.97, down 0.44% with a bullish technical signal from moving averages. The ETF holds nearly 2,000 small-cap stocks and has gained 22.1% year-to-date, outperforming major indices. Recent news highlights small-cap strength amid shifting rate expectations, with the Russell 2000 showing its first significant pattern since 1991 according to The Motley Fool (July 6, 2026).

Small-cap exposure offers growth potential during economic expansion but carries higher volatility risks. Current technical support sits at $295 with resistance at $299. The ETF's 26-year track record of 8.6% annualized returns supports long-term positioning, though interest rate sensitivity remains a key monitorable for near-term performance.